How does the EQ-5D-Y Proxy version 1 perform in 3, 4 and 5-year-old children?

Janine Verstraete, Andrew Lloyd, Des Scott, Jennifer Jelsma, Janine Verstraete, Andrew Lloyd, Des Scott, Jennifer Jelsma

Abstract

Background: The EQ-5D-Y Proxy is currently recommended for Health Related Quality of Life (HRQoL) measurement in children aged 4-8 years of age. However, it has only been validated in children over six years of age. The aim of this study was to investigate the performance of the EQ-5D-Y proxy version 1 in children between the ages of 3-6 years.

Methods: A sample of 328 children between 3 and 6 years of age were recruited which included children who were either acutely-ill (AI), chronically-ill (CI) or from the general school going population (GP). The EQ-5D-Y Proxy Version 1 and the PedsQL questionnaires were administered at baseline. The EQ-5D-Y Proxy was administered telephonically 24 h later to children with chronic illnesses to establish test-retest reliability. The distribution of dimensions and summary scores, Cohen's kappa, the intraclass correlation coefficient, Pearson's correlation and Analysis of variance were used to explore the reliability, and validity of the EQ-5D-Y for each age group. A single index score was estimated using Latent scores and Adult EQ-5D-3 L values (Dolan).

Results: The groups included 3-year olds (n = 105), 4-year olds (n = 98) and 5-years olds (n = 118). The dimension Looking after Myself had the greatest variability between age groups and had the highest rate of problems reported. Worried, Sad or Unhappy and Pain or Discomfort were not stable across time in test-retest analysis. The Visual Analogue Scale (VAS), and single index scores estimated using the latent values and Dolan tariff had good test retest (except for the latent value scores in a small number of 4-year olds). EQ-5D-Y scores for all ages had small to moderate correlations with PedsQL total score. The EQ-5D-Y discriminated well between children with a health condition and the general population for all age groups. Caregivers reported difficulty completing the Looking after Myself dimension due to age-related difficulties with washing and dressing.

Conclusion: The dimension of Looking after Myself is problematic for these young children but most notably so in the 3 year old group. If one considers the summary scores of the EQ-5D-Y Proxy version 1 it appears to work well. Known group validity was demonstrated. Concurrent validity was demonstrated on a composite level but not for individual dimensions of Usual Activities or Worried, Sad or Unhappy.. The observable dimensions demonstrated stability over time, with the inferred dimensions (Pain or Discomfort and Worried, Sad or Unhappy) less so, which is to be expected. Further work is needed in exploring either the adaptation of the dimensions in the younger age groups.

Keywords: EQ-5D-Y; HRQoL; Health Related Quality of Life; Proxy; child; pre-school.

Conflict of interest statement

All the authors are members of the EuroQoL Research Group. The main outcome measure, the EQ-5D-Y Proxy was developed by the EuroQoL Group.

Figures

Fig. 1
Fig. 1
The distribution of responses to EQ-5D-Y Proxy 1 dimensions at baseline by age group. 1* = no problems, 2* = some problems, 3* = a lot of problems. 3 years N = 105; 4 years N = 98; 5 years N = 118
Fig. 2
Fig. 2
Known group validity of the EQ-5D-Y Latent score across age groups and health condition. Health condition implies attendance at a health institution for acute or chronic illness
Fig. 3
Fig. 3
Known group validity of the EQ-5D Dolan tariff across age groups and health condition. Health condition implies attendance at a health institution for acute or chronic illness
Fig. 4
Fig. 4
Known group validity of the EQ-5D-Y VAS score across age groups and health condition. Health condition implies attendance at a health institution for acute or chronic illness

References

    1. World Health Organization. Millennium Development Goals Fact Sheet. World Health Organization. 2013. Available from: .
    1. Janssens A, Thompson Coon J, Rogers M, Allen K, Green C, Jenkinson C, Tennant A, Logan S, Morris C. A systematic review of generic multidimensional patient-reported outcome measures for children, part I: Descriptive characteristics. Value Heal. 2015;18(2):315–333. doi: 10.1016/j.jval.2014.12.006.
    1. Janssens A, Rogers M, Gumm R, Jenkinson C, Tennant A, Logan S, Morris C. Measurement properties of multidimensional patient-reported outcome measures in neurodisability: A systematic review of evaluation studies. Dev Med Child Neurol. 2016;58(5):437–451. doi: 10.1111/dmcn.12982.
    1. The WHOQOL Group The World Health Organization Quality of Life Assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409. doi: 10.1016/0277-9536(95)00112-K.
    1. Raat H, Mohangoo AD, Grootenhuis MA. Pediatric health-related quality of life questionnaires in clinical trials. Curr Opin Allergy Clin Immunol. 2006;6(3):180–185. doi: 10.1097/01.all.0000225157.67897.c2.
    1. Eiser C, Morse R. Can parents rate their child’s health-related quality of life? Results of a systematic review. Qual Life Res. 2001;10(4):347–357. doi: 10.1023/A:1012253723272.
    1. Varni JW, Burwinkle TM, Lane MM. Health-related quality of life measurement in pediatric clinical practice: An appraisal and precept for future research and application. Health Qual Life Outcomes. 2005;3(34):34–43. doi: 10.1186/1477-7525-3-34.
    1. Eiser C, Varni JW. Health-related quality of life and symptom reporting: Similarities and differences between children and their parents. Eur J Pediatr. 2013;172(10):1299–1304. doi: 10.1007/s00431-013-2049-9.
    1. Matza LS, Patrick DL, Riley A, Alexander J, Rajmil L, Pleil A, Bullinger M. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Heal. 2013;16(4):461–479. doi: 10.1016/j.jval.2013.04.004.
    1. Niemitz M, Seitz DCM, Oebels M, Schranz D, Hövels-Gürich H, Hofbeck M, Kaulitz R, Galm C, Berger F, Nagdymann N, Stiller B, Borth-Bruhns T, Konzag I, Balmer C, Goldbeck L. The development and validation of a health-related quality of life questionnaire for pre-school children with a chronic heart disease. Qual Life Res. 2013;22(10):2877–2888. doi: 10.1007/s11136-013-0414-9.
    1. Ramos-Goñi JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, Devlin N. International Valuation Protocol for the EQ-5D-Y-3L. Pharmacoeconomics. 2020;(0123456789). Available from: 10.1007/s40273-020-00909-3.
    1. Mott DJ, Shah, Ramos-Goñi JM, Devlin NJ, Rivero-Arias O. Valuing EQ-5D-Y health states using a discrete choice experiment: do adult and adolescent preferences differ? OHE Research Paper. London: Office of Health Economics; 2019. Available at: .
    1. EuroQol Research Foundation. EuroQoL. December. 2016 [cited 2017 Feb 7]. Available from: .
    1. Gusi N, Perez-Sousa M, Gozalo-Delgado M, Olivares P. Validity and Reliability of the spanish EQ-5D-Y proxy version. An Pediatr. 2014;81(4):212–219. doi: 10.1016/j.anpedi.2013.11.028.
    1. Wille N, Badia X, Bonsel G, Burstrom K, Cavrini G, Devlin N, Egmar A-C, Greiner W, Gusi N, Herdman M, Jelsma J, Kind P, Ravens-sieberer U, Scalone L. Development of the EQ-5D-Y : a child-friendly version of the EQ-5D. Qual Life Res. 2010;19:875–886. doi: 10.1007/s11136-010-9648-y.
    1. Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Gusi N, Herdman M, Jelsma J, Kind P, Olivares PR, Scalone L, Greiner W. Feasibility, reliability, and validity of the EQ-5D-Y: Results from a multinational study. Qual Life Res. 2010;19(6):887–897. doi: 10.1007/s11136-010-9649-x.
    1. Scott D, Jelsma J. A comparison of the validity of the two EQ-5D-Y proxy version in acutely and chronically ill children in South AFrica. A cross sectional analytical descriptive study - preliminary results. In: Poster: EuroQoL Plenary Meeting, Berlin. 2016.
    1. Varni JW, Seid M, Knight TS, Uzark K, Szer IS. The PedsQL TM 4 . 0 Generic Core Scales : Sensitivity , Responsiveness , and Impact on Clinical Decision-Making. J Behav Med. 2002;25(2):175–193. doi: 10.1023/A:1014836921812.
    1. Boyle SE, Jones GLWS. Quality of Life, Physical Activity, Weight Status and Diet in Adolescent School Children. Qual Life Res. 2010;19(7):943–954. doi: 10.1007/s11136-010-9659-8.
    1. Pardo-Guijarro MJ, Woll B, Moya-Martínez P, Martínez-Andrés M, Cortés-Ramírez EE, Martínez-Vizcaíno V. Validity and reliability of the Spanish sign language version of the KIDSCREEN-27 health-related quality of life questionnaire for use in deaf children and adolescents. Gac Sanit. 2013;27(4):318–324. doi: 10.1016/j.gaceta.2012.11.003.
    1. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr Off J Ambul Pediatr Assoc. 2003;3(6):329–341.
    1. Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003;56(8):730–735. doi: 10.1016/S0895-4356(03)00084-2.
    1. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQoL: Results from a UK General Population Survey. York: The Publications Office, Centre for Health Economics, University of York; 1995. pp. 1–19.
    1. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. doi: 10.2307/2529310.
    1. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155–163. doi: 10.1016/j.jcm.2016.02.012.
    1. University of Cambridge MRC Cognition & Brain Sciencesn Unit. Rules of thumb on magnitudes of effect sizes. 2009. Available from: .
    1. Scott D, Ferguson GD, Jelsma J. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape , South Africa : psychometric properties , feasibility and usefulness - a longitudinal , analytical study. Health Qual Life Outcomes. 2017;1–14. Available from: 10.1186/s12955-017-0590-3.
    1. Scalone L, Tomasetto C, Matteucci MC, Selleri P, Broccoli S, Pacelli B, Cavrini G. Assessing quality of life in children and adolescents : development and validation of the Italian version of the EQ-5D-Y. Ital J Public Health. 2011;8(4):331–341.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere